COVID-19: Clinical profile of patients in a hospital in the State of Sergipe
DOI:
https://doi.org/10.33448/rsd-v10i14.21808Keywords:
Epidemiology; Coronaviruses; Comorbidities.Abstract
Due to the recent outbreak of the coronavirus, millions of people have been affected worldwide. Symptoms such as fever, cough, fatigue and dyspnea are more prevalent in patients with comorbidities. Conduct a reserch of epidemiological, clinic symptons and comorbidities in patients with COVID-19 in serious and mild conditions in a Hospital in the state of Sergipe. A descriptive study was performed, through a data collection from records of patients infected with COVID-19 at the Regional public Hospital of Itabaiana Dr. Pedro Garcia Moreno, located in Itabaiana, in a period of three months. The total sample was 64 volunteers, being divided into two groups of 32 patients, one group in a mild condition (GC) and another group in a serious condition (GT) The mean age of the present study was 58.3 years, with males (68.5%) and pheoderm ethnicity (62.5%) being more prevalent. The average systolic blood pressure (SBP) was 122 mmHg and the average diastolic blood pressure was 79.8 mmHg. The present symptoms was asthenia (90.63%), dyspnea (84.38%), headache (73.44%), cough (68.8%), fever (65.6%), dysgeusia (54.7%), sore throat (6.26%) and diarrhea (4.7%). The most prevalent comorbidities were Systematic Arterial Hypertension (SAH) of 42.8% and Diabetes Mellitus (DM) of 15.63%. It is concluded that the most affected ethnicity was pheoderm, the most common symptom in both groups (GT and GC) was asthenia and diarrhea was the least prevalent symptom in both groups. The most prevalent comorbidities were SAH and DM.
References
Adil, M. T., Rahman, R., Whitelaw, D., Jain, V., Al-Taan, O., Rashid, F., Munasinghe, A., & Jambulingam, P. (2021). SARS-CoV-2 and the pandemic of COVID-19. Postgrad Med J, 97(1144), 110-116. https://doi.org/10.1136/postgradmedj-2020-138386
Badawi, A., & Vasileva, D. (2021). Comparative profile for COVID-19 cases from China and North America: Clinical symptoms, comorbidities and disease biomarkers. World J ClinClin Cases, 9(1), 118-132. https://doi.org/10.12998/wjcc.v9.i1.118
Barry, M., Althabit, N., Akkielah, L., AlMohaya, A., Alotaibi, M., Alhasania, S., Aldrees, A., AlRajhi, A., AlHiji, A., Almajid, F., AlSharidi, A., Al-Shahrani, F. S., Alotaibi, N. H., & AlHetheel, A. (2021). Clinical characteristics and outcomes of hospitalized COVID-19 patients in a MERS-CoV referral hospital during the peak of the pandemic. International journal of infectious Diseases, (106), 43-51. https://doi.org/10.1016/j.ijid.2021.03.058
Bulfone, T. C., Malekinejad, M., Rutherford, G. W., & Razani, N. (2020). Outdoor Transmission of SARS-CoV-2 and Other Respiratory Viruses: A Systematic Review. The Journal of Infectious Diseases, 223(4), 550-561. https://doi.org/10.1093/infdis/jiaa742
Deshmukh, V., Tripathi, S., Pandey, A., Deshmukh, V., Vykoukal, J., Patil, A., & Sontakke, B. (2020). COVID-19: a conundrum to decipher. European Review for Medical and Pharmacological Sciences, 24(10), 5830-5841. https://doi.org/10.26355/eurrev_202005_21378
Gómez-Ochoa, S. A., Franco, O. H., Rojas, L. Z., Raguindin, P. F., Roa-Díaz, Z. M., Wyssmann, B. M., Guevara, S. L. R., Echeverría, L. E., Glisic, M., & Muka, T. (2020). COVID-19 in Health-Care Workers: A Living Systematic Review and Meta-Analysis of Prevalence, Risk Factors, Clinical Characteristics, and Outcomes. Am J Epidemiol, 190(1), 16-175. https://doi.org/10.1093/aje/kwaa191
Koh, W. C., Naing, L., Chaw, L., Rosledzana, M. A., Alikhan, M. F., Jamaludin, S. A., Amin, F., Omar, A., Shazli, A., Griffith, M., Pastore, R., & Wong, J. (2020). What do we know about SARS-CoV-2 transmission? A systematic review and metaanalysis of the secondary attack rate and associated risk factors. PLOS ONE, 15(10), e0240205. https://doi.org/10.1371/journal.pone.0240205
Kopel, J., Perisetti, A., Roghani, A., Aziz, M., Gajendran, M., & Goyal, H. (2020). Racial and Gender-Based Differences in COVID-19. Frontiers in Public Heath, (8). https://doi.org/10.3389/fpubh.2020.00418
Kumar, M., Taki, K., Gahlot , R., Sharma, A., & Dhangar, K. (2020). A chronicle of SARS-CoV-2: Part-I - Epidemiology, diagnosis, prognosis, transmission and treatment. Science of the Total Environment, (734), 139278. https://doi.org/10.1016/j.scitotenv.2020.139278
Khan, M., Adil, S. F., Alkhathlan, H. Z., Tahir, M. N., Saif, S., Khan, M., & Khan, S. T. (2020). COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far. Molecules, 26(1), E39. https://doi.org/10.3390/molecules26010039
Li, L., Li, R., Wu, Z., Yang, X., Zhao, M., Liu, J., & Chen, D. (2020). Therapeutic strategies for critically ill patients with COVID-19. Annals of Intensive Care, 10(1), 45. https://doi.org/10.1186/s13613-020-00661-z
Liguoro, I., Pilotto, C., Bonanni, M., Ferrari, M. E., Pusiol, A., Nocerino, A., Vidal, E., & Cogo, P. (2020). SARS-COV-2 infection in children and newborns: a systematic review. European Journal of Pediatrics, 179(7), 1029-1046. https://doi.org/10.1007/s00431-020-03684- 7
Ludvigsson, J. F. (2020). Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatrica, 109(6), 1088-1095. https://doi.org/10.1111/apa.15270
Madewell, Z. J., Yang, Y., Longini Jr, I. M., Halloran, M. E., & Dean, N. E. (2020). JAMA Network Open, 3(12), e2031756. https://doi.org/10.1001/jamanetworkopen.2020.31756
Mackey, K., Ayers, C. K., Kondo, K. K., Saha, S., Advani, S. M., Young, S., Spencer, H., Rusek, M., Anderson, J., Veazie, S., Smith, M., & Kansagara, D. (2020). Racial and Ethnic Disparities in COVID-19–Related Infections, Hospitalizations, and Deaths. Annals of Internal Medicine, 174(3), 362-373. https://doi.org/10.7326/M20-6306
Martínez, I. P., Torres, L. A. P. d., Lama, J. G., García, C. J., Montero, R. S., & Garrido, F. R. (2020). Características clínico-epidemiológicas de la infección por el virus SARS-CoV-2 en médicos de familia: un estudio de casos y controles. Atencion Primaria, (53), 101956. https://doi.org/10.1016/j.aprim.2020.12.001
Mehta, N. S., Mytton, O. T., Mullins, E. W. S., Fowler, T. A., Falconer, C. L., Murphy, O. B., Langenberg, C., Jayatunga, W. J. P., Eddy, D. H., & Nguyen-Van-Tam, J. S. (2020). SARS-CoV-2 (COVID-19): What Do We Know About Children? A Systematic Review. Clinical Infectious Diseases, 71(9), 2469-2479. https://doi.org/10.1093/cid/ciaa556
Nascimento, M. d. M. (2021). Clinical characteristics of 1544 Brazilians aged 60 years and over with laboratory evidence for SARS-CoV-2. Archives of Gerontology and Geriatrics, (96), 104462. https://doi.org/10.1016/j.archger.2021.104462
Raghuvamsi, P. V., Tulsian, N. K., Samsudin, F., Qian, X., Purushotorman, K., Yue, G., Kozma, M. M., Hwa, W. Y., & Lescar, J. (2021). SARS-CoV-2 S protein:ACE2 interaction reveals novel allosteric targets. Biochemistry and Chemical BiologyStructural Biology and Molecular Biophysics, (10), e63646. https://doi.org/10.7554/eLife.63646
Rodrigues, M. d. B., Chong-Silva, D. C., & Neto, H. J. C. (2021). Guia prático para produção e submissão de artigos. Sociedade Brasileira de Pediatria, (5).
Salzberger, B., Buder, F., Lampl, B., Ehrenstein, B., Hitzenbichler, F., Holzmann, T., Schmidt, B., & Hanses, F. (2020). Epidemiology of SARS‑CoV‑2. Infection, 49(2), 233-239. https://doi.org/10.1007/s15010-020-01531-3
Walsh, K. A., Jordan, K., Clyne, B., Rohde, D., Drummond, L., Byrne, P., Ahern, S., Carty, P. G., O’Brien, K. K., O’Murchu, E., O’Neill, M., Smith, S. M., Ryan, M., & Harrington, P. (2020). SARS-CoV-2 detection, viral load and infectivity over the course of an infection. Journal of infection, 81(3), 357-371. https://doi.org/10.1016/j.jinf.2020.06.067
Yang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., Guo, Q., ji, R., Wang, H., Wang, Y., & Zhou, Y. (2020). Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. International Journal of infectious Diseases, (94), 91-95. https://doi.org/10.1016/j.ijid.2020.03.017
Zhang, X., Huang, H., Zhuang, D., Nasser, M. I., Yang, M., Zhu, P., & Zhao, M. (2020). Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2. Infectious Diseases of Poverty, 9(1), 99. https://doi.org/10.1186/s40249-020-00691-6
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Mário Sérgio Reis Roriz; Halley Ferraro Oliveira; Thadeu Roriz Silva Cruz; Christiana Flávia Fontan Roriz; Fernando José Camelo de Lima; José Augusto Santos da Silva; Felipe José Menezes Machado Santos; Matheus Roriz Silva Cruz; Edvaldo Dória dos Anjos; João dos Santos Lima Júnior; Silvia Girlane Nunes da Silva
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
